Sweden Achieves 18-Year Ahead of Schedule Smoke-Free Target

Dec.08.2022
Sweden Achieves 18-Year Ahead of Schedule Smoke-Free Target
Sweden achieves smoking rate of 5.6%, becoming the only European country to reach EU's no smoking goal ahead of schedule.

Swedish authorities have officially confirmed that the smoking rate in Sweden has now decreased to 5.6%. This makes Sweden the only European country to be on track to achieving the EU's goal of becoming smoke-free, achieving this target 18 years ahead of the 2040 deadline.


At an event organized by the Stockholm Snus Nicotine Committee, participants evaluated Sweden's incredible achievements and leadership in the fight against smoking. The country is on track to become the world's first to be defined as "smoke-free" and have a smoking population of less than 5%.


Since the 1980s, Sweden has achieved a remarkable feat unmatched by any other country in the world, reducing its smoking rate from 35% to less than 6%. The country now boasts the second lowest smoking rate in Europe, which is only half that of the next lowest country. In contrast, the average smoking rate in the EU is around 23%, which is four times higher than Sweden's. Notably, Europe also has the lowest tobacco-related death rate in the world.


On November 30, 2022, a group of leading public health experts, consumer advocates, and harm reduction professionals celebrated this achievement in Stockholm and once again called on policymakers around the world to ensure the availability of less harmful smoking alternatives as aids for quitting smoking.


Delon Human, President and Stockholm event organizer of Health Diplomats, stated during the event that if all 1.1 billion smokers worldwide were to switch to a less harmful nicotine replacement product, it could prevent disease and save millions of lives globally. Sweden has found a solution for smokers and we must work together to follow their example and save lives around the world.


This incredible success story sheds light on Sweden's secret to success, where the key factor is an open-minded attitude towards less harmful alternatives to smoking. While snus has long been at the forefront of harm reduction efforts, in recent years, nicotine pouches and e-cigarettes have become another valuable tool for Swedish smokers looking to quit.


Sweden's gradual harm reduction approach differs significantly from the measures proposed by the International Tobacco Control Organization. Advocates for harm reduction in the EU have been pushing for reductions in harm to be included in cancer prevention plans. Despite the fact that the Tobacco Control Framework Convention recognizes harm reduction as a viable option, the World Health Organization continues to refuse to acknowledge its benefits.


Professor Karl Fagerström stated during the event, "Sweden's upcoming presidency of the European Union is a great opportunity to share the country's successful stories, which accounts for 5% of the EU, with other member countries. We hope that Sweden will generously share this knowledge with other nations.


Speakers at the conference emphasized the need for evidence-based and comprehensive tobacco control policies. Therefore, it is imperative to implement the concept of reducing tobacco harm on a broader level to support smoking cessation.


Ensuring that the smoking alternatives with lower health risks are inexpensive, accessible, and easy to use, is a crucial prerequisite for Sweden's success in replicating it in other countries.


The Nicotine Oral Committee is a global nonprofit organization dedicated to assisting governments, health officials, and the public in building knowledge about nicotine oral products, challenging unfounded biases and stereotypes. The organization deals with political, scientific, consumer matters, and related product innovations. Their views are independent of any brand/manufacturer and are tailored to the individual and population health needs of adult smokers.


2FIRSTS will continue to follow and report on this topic. Updates will be available on the 2FIRSTS app. Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Special Report | Russian Vape Compromise Faces First Hurdles
Special Report | Russian Vape Compromise Faces First Hurdles
Russia’s regional vape-ban model is facing early legal and political tests, as Perm Krai moves ahead before federal legislation is fully adopted. The case highlights uncertainty over regional authority, concerns from business groups about market fragmentation, and the risk that pressure against regional bans could revive calls for a stricter nationwide prohibition.
Industry Insight
May.28
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
A University of Louisville research team published a study in an American Heart Association journal suggesting that synthetic cooling agents used in e-cigarettes, including WS-3 and WS-23, may disrupt cardiac electrical activity and increase arrhythmia risk. In animal experiments, WS-23 tripled premature heartbeats.
Jun.16
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
U.S. Customs and Border Protection (CBP) announced that more than 18 million illegal e-cigarettes valued at over $175 million were seized during “Operation Red Mist,” a joint enforcement initiative involving the U.S. Coast Guard and the FDA. The operation primarily targeted maritime vape shipments originating from China and focused on combating illicit importation, transportation, and distribution activities.
Regulations
May.14
Nicotine Beyond Tobacco? Cell Study Signals Emerging Shift in Production Systems
Nicotine Beyond Tobacco? Cell Study Signals Emerging Shift in Production Systems
Researchers at the Chinese Academy of Sciences reconstructed nicotine biosynthesis in non-tobacco plants and yeast systems, highlighting how advances in synthetic biology could gradually reshape future nicotine production technologies and challenge regulatory frameworks built around tobacco-derived definitions.
Special Report
May.07
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands reported first-quarter 2026 results on May 7, covering the period ended March 31, 2026. Total consolidated net sales were $124.3 million, up 16.8% year on year. Gross profit was $68.3 million, up 14.6%, while net income fell 19.0% to $11.7 million. Adjusted EBITDA declined 6.5% to $25.9 million.
May.08 by 2FIRSTS.ai
Disposable Vape Ban Shifts Purchasing Formats as UK Vape Volume Falls 10.3%
Disposable Vape Ban Shifts Purchasing Formats as UK Vape Volume Falls 10.3%
Data from convenience insight agency Talysis shows that the value of tobacco, vapes and smoking alternatives in the independent convenience sector fell by 4.4% in the first quarter of 2026, while volume fell by 7.8%. The vaping subcategory declined by 3.9% in value and 10.3% in volume over the same period. Talysis said the impact of the disposable vape ban continues to pressure turnover and footfall.
May.08 by 2FIRSTS.ai